Results 51 to 60 of about 1,921 (191)

Both OX1R and OX2R are expressed in primary rat astrocytes.

open access: yes, 2014
A: Colocalization of OX1R (Green) and GFAP (Red) in cultured rat astrocytes. n = 4, Scale bar  = 50 µm. The white pane indicating enlarged area. B: Colocalization of OX2R (Red) and GFAP (Green) in cultured rat astrocytes. n = 4, Scale bar  = 50 µm.
Xiao-Wei Yu (130650)   +9 more
core   +1 more source

Signaling of ghrelin at GHSR1b and OX1R receptor heterodimers [PDF]

open access: yesMolecular Biology of the Cell, 2021
Wang, Qiuling   +8 more
openaire   +2 more sources

Resuscitation therapy for traumatic brain injury-induced coma in rats: mechanisms of median nerve electrical stimulation

open access: yesNeural Regeneration Research, 2015
In this study, rats were put into traumatic brain injury-induced coma and treated with median nerve electrical stimulation. We explored the wake-promoting effect, and possible mechanisms, of median nerve electrical stimulation.
Zhen Feng   +3 more
doaj   +1 more source

Targeting Orexin 2 Receptors in Idiopathic Hypersomnia and Narcolepsy: A Randomised Phase 1b Proof‐Of‐Concept Study of Alixorexton

open access: yesJournal of Sleep Research, EarlyView.
Orexin 2 receptor agonists have demonstrated that targeting the orexin system may address symptoms of central disorders of hypersomnolence. Results of this phase 1 study support the phase 2 clinical evaluation of oral alixorexton in patients with IH, NT2 and NT1.
Ronald R. Grunstein   +10 more
wiley   +1 more source

Interaction of OX1R and Dynlt1 in mammalian cells.

open access: yes, 2013
HEK293 cells were transfected with expression vectors for Myc-Dynlt1 and V5-OX1R (0.5 or 2.0 µg DNA, full-length receptor) or corresponding empty vector.
David Duguay (216295)   +5 more
core   +1 more source

Daridorexant‐ Case Report of Possible Side‐Effect in Rare Mitochondrial Disorder

open access: yesJournal of Sleep Research, EarlyView.
ABSTRACT This case report describes a 40‐year‐old woman with maternally inherited diabetes and deafness (MIDD), a rare mitochondrial disorder, who received treatment with daridorexant due to severe chronic insomnia. She developed progression of her MIDD symptoms during treatment.
Sven Svedmyr, Joel Bergqvist
wiley   +1 more source

Orexin A receptor 1(OX1R) activation increases expression of cytokines in PC12 cells

open access: yesThe FASEB Journal, 2019
Orexin A is a multifunctional neuropeptide that regulates arousal , wakefulness, appetite and cardiovascular function.
Wafa Fhad Alharbi   +3 more
openaire   +1 more source

Different Molecular/Behavioral Endophenotypes in C57BL/6J Mice Predict the Impact of OX1 Receptor Blockade on Binge-Like Ethanol Intake

open access: yesFrontiers in Behavioral Neuroscience, 2017
Ethanol (EtOH) research has focused on stages of dependence. It is of paramount importance to more deeply understand the neurobehavioral factors promoting increased risk for EtOH binge drinking during the early stages of the addiction cycle.
Manuel Alcaraz-Iborra   +6 more
doaj   +1 more source

Functional magnetic resonance imaging reveals different neural substrates for the effects of orexin-1 and orexin-2 receptor antagonists. [PDF]

open access: yesPLoS ONE, 2011
Orexins are neuro-modulatory peptides involved in the control of diverse physiological functions through interaction with two receptors, orexin-1 (OX1R) and orexin-2 (OX2R).
Alessandro Gozzi   +11 more
doaj   +1 more source

Short‐Term Efficacy and Safety of Oral Selective Orexin‐2 Receptor Agonists in Narcolepsy Type 1: An Updated Systematic Review and Meta‐Analysis of Randomized Trials

open access: yesNeuropsychopharmacology Reports, Volume 46, Issue 4, December 2026.
Five randomized trials included 550 participants. Planned treatment periods spanned 6–12 weeks. OX2R agonists improved wakefulness and reduced sleepiness. Weekly cataplexy rates decreased by approximately 66%. Treatment‐emergent adverse events increased compared with placebo. Wakefulness improvements varied substantially across included trials.
Aasim Ali   +10 more
wiley   +1 more source

Home - About - Disclaimer - Privacy